Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1998
06/02/1998US5759811 Mutant human hedgehog gene
06/02/1998US5759804 Culture product
06/02/1998US5759789 Prostaglandin receptor EP2
06/02/1998US5759788 High affinity L-proline transporter polypeptides; antibodies and immunoassays specific for them
06/02/1998US5759782 Cellular apoptosis susceptibility protein (CSP) and antisense CSP
06/02/1998US5759776 Targets for breast cancer diagnosis and treatment
06/02/1998US5759775 Hybridization; amplification
06/02/1998US5759583 Polylactic/glycolic acid copolymer, bioactive agent and quaternary ammonium surfactant
06/02/1998US5759565 Galenic compositions comprising calcitonin and their use
06/02/1998US5759550 Method for suppressing xenograft rejection
06/02/1998US5759547 Methods and compositions for treatment of angiogenic diseases
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759545 Method for the treatment of HIV-I infection
06/02/1998US5759544 Antibody-containing oral composition for suppression of periodontal disease
06/02/1998US5759542 Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
06/02/1998US5759541 Polypeptides
06/02/1998US5759539 Oxidizing ethanol to acetate in the blood
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759535 Immunotherapeutic strategies for the treatment of cancer
06/02/1998US5759534 Methods of treating disease using sertoli cells and allografts or xenografts
06/02/1998US5759533 Neutrophil-activating peptide-2
06/02/1998US5759517 Hemoglobins as drug delivery agents
06/02/1998US5759516 Peptide-metal ion pharmaceutical preparation
06/02/1998US5759515 Polyvalent peptide pharmaceutical applications
06/02/1998US5759514 Composition for delivery of toxic radioisotopes to the cell nucleus and use
06/02/1998CA2012278C Mutant of microbacterium, a strain 851r, and a process for producing 851r nutrient solution by application of the strain
06/02/1998CA1339894C Fusion proteins with a eukaryotic ballast portion
06/02/1998CA1339892C Preparation of polypeptides having human gamma enterferon activity
05/1998
05/29/1998CA2222483A1 Composition for treating cornea
05/29/1998CA2219849A1 Composition for cosmetic, pharmaceutical or dietetic use based on an amino sugar and/or a polyhydroxylic acid
05/28/1998WO1998022617A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer
05/28/1998WO1998022616A1 ANTI-HUMAN VEGF RECEPTOR F1t-1 MONOCLONAL ANTIBODY
05/28/1998WO1998022608A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998WO1998022588A2 An improved method for the production and purification of adenoviral vectors
05/28/1998WO1998022587A2 Pituitary-tumor-transforming-genes, and related products
05/28/1998WO1998022586A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR
05/28/1998WO1998022585A1 HUMAN POLYHOMEOTIC 2(hph2) ACTS AS AN ONCOGENE
05/28/1998WO1998022583A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION
05/28/1998WO1998022582A1 Human cancer regression antigen protein
05/28/1998WO1998022580A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
05/28/1998WO1998022579A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998WO1998022577A1 Fusion proteins having increased half-lives
05/28/1998WO1998022508A2 Process for tumour cell depletion of cd34-positive cells
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022505A1 Soluble polypeptides
05/28/1998WO1998022504A1 Novel semaphorin genes (i)
05/28/1998WO1998022502A1 Gene product over expressed in cancer cells
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022500A2 Modulation of interactions between myosin and integrins
05/28/1998WO1998022499A2 Arretin, a neurite outgrowth modulator, antibodies thereto and uses thereof
05/28/1998WO1998022498A1 Cyclic hexapeptides having antibiotic activity
05/28/1998WO1998022497A1 Preprotachykinin-c gene encoding substance z tachykinin precursor
05/28/1998WO1998022496A2 Antiviral peptide derivatives
05/28/1998WO1998022495A2 De-analoques and derivatives of bradykinin 1-5 fragment(bk1-5) and their retropeptides having antikinin activity and uses thereof
05/28/1998WO1998022494A2 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS
05/28/1998WO1998022493A2 N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
05/28/1998WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998WO1998022438A1 Cyclic imines as pesticides
05/28/1998WO1998022169A1 Insulin delivery enhanced by coached breathing
05/28/1998WO1998022149A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
05/28/1998WO1998022142A1 Antisense oligonucleotide compositions for selectively killing cancer cells
05/28/1998WO1998022140A2 Hybrid compositions for intracellular targeting
05/28/1998WO1998022139A1 Detection of galectin-4 in human tumors
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998022136A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
05/28/1998WO1998022134A1 BIOSYNTHETIC GENE murG FROM $i(STREPTOCOCCUS PNEUMONIAE)
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022132A1 A method and composition for enabling passage through the blood-brain barrier
05/28/1998WO1998022131A2 Modulators of ovarial apoptosis related to iap
05/28/1998WO1998022130A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye
05/28/1998WO1998022129A1 Therapeutic agent for ophthalmic diseases
05/28/1998WO1998022128A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/28/1998WO1998022127A1 Pretreatment with growth factors to protect against cns damage
05/28/1998WO1998022126A1 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
05/28/1998WO1998022125A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
05/28/1998WO1998022124A1 Use of growth hormone secretagogue compound for treating cardiac failure or related vascular dysfunction
05/28/1998WO1998022123A1 Agent for the metabolic treatment of multiple sclerosis
05/28/1998WO1998022122A1 Alkyl peptide amides and applications
05/28/1998WO1998022121A1 Reductive alkylation of glycopeptide antibiotics
05/28/1998WO1998022120A1 Diagnostic and therapeutic reagents for alzheimer's disease
05/28/1998WO1998022107A1 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
05/28/1998WO1998022106A1 Pharmaceutical composition
05/28/1998WO1998022089A1 Pharmaceutical composition based on a lipid matrix system
05/28/1998WO1998022082A1 Sphingomyelinase compositions and use thereof
05/28/1998WO1998021979A1 Method for increasing the efficiency of feed conversion in animals
05/28/1998WO1998021972A2 Compounds with improved inductive effect on cartilage and bones
05/28/1998WO1998016551A3 Variants of vascular endothelial cell growth factor having antagonistic properties
05/28/1998WO1998012328A3 Human bad polypeptides, encoding nucleic acids and methods of use
05/28/1998WO1998008535A3 Method of causing selective immunosuppression using HL-60-related lectins
05/28/1998WO1998007862A3 Chemokine beta-16
05/28/1998DE19649098A1 Pharmaceutical, cosmetic and other compositions containing protease
05/28/1998DE19649097A1 Pharmaceutical or cosmetic compositions comprising lipase(s)
05/28/1998DE19649096A1 Pharmaceutical, cosmetic and other compositions containing glycosidase
05/28/1998DE19648715A1 DNA encoding human interleukin-16
05/28/1998DE19648209A1 Verfahren zur Tumorzelldepletion CD34-positiver Zellen Method for Tumorzelldepletion CD34-positive cells
05/28/1998DE19648011A1 Cyclische Imine Cyclic imines
05/28/1998CA2633660A1 Method for treating symptoms of diabetes
05/28/1998CA2275438A1 Improved methods for transducing cells
1 ... 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 ... 3163